Novartis Investigative Site

Candiolo (TO), Piedmont 10060

0 studies enrolling now · 3 studies all time

What they study most

Cancer, Melanoma, Neoplasms, Breast, Renal Cell Carcinoma (RCC)

Studies at this site

• A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma — Completed
• A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC) — Completed
• EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer — APPROVED_FOR_MARKETING